ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Morphotek inks license deal with BlissBio
biospectrumasia
April 11, 2018BlissBio has an exclusivity option to expand the territory beyond China to the global market and to develop therapeutic ADCs to two additional undisclosed oncology targets. -
Morphotek Launches ADC Services Business
contractpharma
April 05, 2017Aligns antibody engineering and clinical development assets into a client-focused ADC business
Pharma Sources Insight January 2025
